FDAnews
www.fdanews.com/articles/174354-mynosys-cellular-devices-wins-ce-mark-approval-for-zepto-capsulotomy-device

Mynosys Cellular Devices Wins CE Mark Approval for Zepto Capsulotomy Device

December 7, 2015

Ophthalmic medical device company Mynosys Cellular Devices has won CE mark approval for its Zepto capsulotomy device, which is designed for performing anterior lens capsulotomy during cataract surgery.

The disposable, automated device provides surgeons with round, accurately sized and well-centered capsulotomies without interrupting surgical routine and patient flow.

An alternative to manual capsulorhexis, the device and its handpiece allows capsulotomy alignment with the patient’s visual axis for optimized IOL placement and effective lens positioning. — Michael Cipriano